Search

Displaying results 9171 - 9180 of 9617 in total
  1. Drug

    Milacainide

    go.drugbank.com/drugs/DB20252
    Experimental

    Milacainide has a monoisotopic molecular weight of 311.2 Da.

  2. Drug

    Milfasartan

    go.drugbank.com/drugs/DB20355
    Experimental

    Milfasartan has a monoisotopic molecular weight of 554.21 Da.

  3. Drug

    Setoperone

    go.drugbank.com/drugs/DB20520
    Experimental

    Setoperone has a monoisotopic molecular weight of 401.16 Da.

  4. Drug

    Mespirenone

    go.drugbank.com/drugs/DB20625
    Experimental

    Mespirenone has a monoisotopic molecular weight of 426.19 Da.

  5. Drug

    Propyperone

    go.drugbank.com/drugs/DB20765
    Experimental

    Propyperone has a monoisotopic molecular weight of 388.25 Da.

  6. Drug

    Carperone

    go.drugbank.com/drugs/DB21088
    Experimental

    Carperone has a monoisotopic molecular weight of 350.2 Da.

  7. Drug

    Pentamustine

    go.drugbank.com/drugs/DB21291
    Experimental

    Pentamustine has a monoisotopic molecular weight of 221.09 Da.

  8. Drug

    Izilendustat

    go.drugbank.com/drugs/DB21532
    Experimental

    Izilendustat has a monoisotopic molecular weight of 433.18 Da.

  9. Drug

    Civorebrutinib

    go.drugbank.com/drugs/DB21641
    Experimental

    Civorebrutinib has a monoisotopic molecular weight of 463.15 Da.

  10. Drug

    YKP-1358

    go.drugbank.com/drugs/DB06109
    Experimental

    YKP1358 is a novel serotonin (5-HT2A) and dopamine (D2) antagonist that has demonstrated potent activity in animals that relates to both positive and negative symptoms of schizophrenia.